分支支架与颈锁骨下动脉旁路在2区TEVAR的长期结局:倾向匹配研究
单中心回顾性队列研究比较2区TEVAR中TBE与CS-TEVAR的短长期结局。倾向匹配55对患者,住院死亡和卒中无差异,6年生存无差异,TBE组1a/1c型内漏免除率显著更高。
要点
- TBE与CS-TEVAR住院死亡和卒中无差异
- 6年生存两组无差异
- TBE组6年1a/1c型内漏免除率显著更高
核心结论
- TBE在2区TEVAR中短期和长期结局与CS-TEVAR相当,是合适患者的合理替代方案。
主要发现
- 全队列平均临床随访3.5±2.6年,技术成功率100%。
- 匹配队列住院死亡1.8% vs 1.8%(p=1.0),卒中3.6% vs 5.5%(p=.65)。
- 6年生存67.0±10.0% vs 76.0±7.9%(p=.21)。
- 6年影像随访1a或1c型内漏免除率97.9±2.1% vs 87.3±4.9%(p=.04)。
临床怎么用
- 在合适患者中,TBE可作为2区TEVAR左锁骨下动脉血运重建的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Revascularisation of the left subclavian artery (LSA) in zone 2 thoracic endovascular aortic repair (TEVAR) is traditionally performed with carotid-subclavian (CS) bypass. A thoracic branch endoprosthesis (TBE) has been developed for endovascular LSA revascularisation during zone 2 TEVAR. This single centre, retrospective cohort study aimed to compare the short and long term outcomes of TBE with TEVAR with CS bypass (CS-TEVAR) in patients requiring zone 2 arch repair. METHODS: One hundred and seventy-two patients underwent zone 2 CS-TEVAR and 66 patients underwent zone 2 TBE from January 2014 to May 2023. The primary outcome was in hospital death; long term outcomes included survival and freedom from type 1a or 1c endoleak. Propensity score matching identified 55 pairs of patients with similar baseline characteristics. Kaplan-Meier curves were plotted for long term survival on clinical follow up and endoleak on imaging follow up. RESULTS: Mean clinical follow up for the entire cohort was 3.5 ± 2.6 years. Technical success was 100%. In the propensity score matched cohort, there was no difference in in hospital death (1.8% vs. 1.8%; p = 1.0) or stroke (3.6% vs. 5.5%; p = .65) between TBE and CS-TEVAR. There was no difference in survival at 6 years (67.0 ± 10.0% vs. 76.0 ± 7.9%; p = .21). TBE patients had statistically significantly higher freedom from type 1a or 1c endoleak (97.9 ± 2.1% vs. 87.3 ± 4.9%; p = .04) on imaging follow up at 6 years. CONCLUSION: TBE demonstrated comparable short and long term outcomes compared with CS-TEVAR and is a reasonable alternative for zone 2 arch repair in suitable patients.
引用
- Guo MH, Kelly J, Wang GJ, et al. Long Term Outcomes of Zone 2 Thoracic Endovascular Aortic Repair with Branched Endoprosthesis or Carotid-Subclavian Bypass: A Propensity Matched Study. Eur J Vasc Endovasc Surg. 2026. PMID: 41912026. doi:10.1016/j.ejvs.2026.03.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。